Abi-Saab Walid
Chief Medical Officer
Abi-Saab Walid has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jul 2, 2026.
On the most recent filing, Abi-Saab Walid is listed as Chief Medical Officer at uniQure N.V. Inside the rolling window, Abi-Saab Walid reported no open-market purchases and 5 open-market sales totaling $2.6M in QURE. The largest disclosed transaction in the window is a sale of 30,000 QURE shares on Jun 30, 2026, worth $1.4M.
Companies traded
Other insiders at QURE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Abi-Saab Walid made?
Abi-Saab Walid has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company since 2026.
Which companies does Abi-Saab Walid trade?
Abi-Saab Walid has filed SEC Form 4 disclosures for 1 company, including QURE.
When was Abi-Saab Walid's most recent SEC Form 4 filing?
Abi-Saab Walid's most recent SEC Form 4 filing on Tracefour is dated Jul 2, 2026.
What is Abi-Saab Walid's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Abi-Saab Walid is listed as Chief Medical Officer.
What is Abi-Saab Walid's total buy and sell value in the current window?
Inside the rolling retention window, Abi-Saab Walid bought $0 and sold $2.6M based on SEC Form 4 filings.
What was Abi-Saab Walid's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 30,000 QURE shares on 2026-06-30, worth $1.4M, per SEC Form 4 filings.